Continuous Thoracic Paravertebral Analgesia for Video-assisted Thoracoscopic Surgery (VATS): Analgesic Effectiveness and Role in Fast-track Surgery

NCT02670759 NA TERMINATED

This study is designed to assess: * The impact of continuous thoracic paravertebral nerve blockade compared to intercostal nerve blockade on the intensity of postoperative pain following VATS in subjects having a Patient Controlled Analgesia (PCA) device as their primary analgesic modality. * The impact of continuous thoracic paravertebral analgesia on length of stay, opioid intake, respiratory function, incidence of side-effects and postoperative complications. The basic hypothesis of this study is that continuous thoracic paravertebral nerve blockade will provide superior postoperative analgesia following VATS when compared to intercostal nerve blockade in patients having a PCA device as their primary analgesic modality. Superior quality of analgesia should contribute to preserve pulmonary function, reduce opioid intake and related side-effects and shorten the hospital stay.

Details

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	NA
Status	TERMINATED
Enrolment	14
Start date	2016-03
Completion	2017-10-01

Conditions

• Postoperative Pain

Interventions

• Continuous infusion of bupivacaine
• Single dose of bupivacaine

Primary outcomes

• Intensity of postoperative pain — 24 hours following surgery
  Will be assessed using a Verbal Numeric Pain Scale (VPNS) from 0 to 10: 0 being no pain at all and 10 being the worst pain imaginable

Countries

Canada